BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1373113)

  • 1. [The palliative treatment of primary hepatocellular carcinoma by chemoembolization].
    Hasan I; Wickenhöfer R; Görich J; Hartlapp JH; Reiser M
    Dtsch Med Wochenschr; 1992 Apr; 117(15):576-80. PubMed ID: 1373113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The results of the chemoembolization of advanced hepatocellular carcinomas. The effect on the survival times, morphological findings and tumor markers].
    Wickenhöfer R; Hasan I; Schüller H; Reiser M; Hartlapp JH
    Rofo; 1992 Apr; 156(4):328-32. PubMed ID: 1373966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of liver resection with sequential transarterial chemoembolization in stage pT3 or pT4 hepatocellular carcinoma].
    Hasse F; Mehring UM; Castaneda F; Jäger H; Mathias KD; Löhlein D
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():208-10. PubMed ID: 9101833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
    Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
    J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment.
    Thong-Ngam D; Thumvijit L; Tangkijvanich P; Janchai A; Mahachai V; Wittayalertpanya S
    J Med Assoc Thai; 2002 Dec; 85(12):1280-7. PubMed ID: 12678165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [-Comparison of lipiodol-assisted chemoembolization versus only conservative therapy in patients with nonresectable hepatocellular carcinomas-].
    Lorenz M; Waldeyer M; Müller HH
    Z Gastroenterol; 1996 Mar; 34(3):205-6. PubMed ID: 8650976
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
    Baur M; Walter R; Gebauer A; Tscholakoff D; Lochs H; Mühlbacher F; Turetschek K; Binder R; Hudec M; Gangl A; Ferenci P; Dittrich C
    Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin].
    Bokemeyer B; Grote R; Schmoll E; Freise J; Schmoll HJ; Galanski M; Schüler A; Schmidt FW
    Dtsch Med Wochenschr; 1989 Jan; 114(4):128-32. PubMed ID: 2536606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival in 46 patients with hepatocarcinoma treated by chemoembolization].
    Gattoni F; Pompili GG; Dova S; Baldini U; Raiteri R; Sacrini A; Uslenghi CM
    Radiol Med; 1994 Sep; 88(3):228-32. PubMed ID: 7938727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
    Phornphutkul K; Handagoon P; Sirivanichai C; Senarat S; Nakamura H
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1239-46. PubMed ID: 1325144
    [No Abstract]   [Full Text] [Related]  

  • 18. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
    Huppert PE; Geissler F; Duda SH; Lauchart W; Dette S; Dietz K; Brambs HJ; Claussen CD
    Rofo; 1994 May; 160(5):425-32. PubMed ID: 7513560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol].
    Pirschel J; Lauchart W
    Helv Chir Acta; 1993 Mar; 59(4):631-6. PubMed ID: 8386147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.